Vigilancia Tecnológica

Morphology of PEG?PCL and DAS@PEG?PCL.AbstractDasatinib (DAS) has recently gained significant interest for its anticancer potential. Yet, the lipophilicity inherent in DAS limited its potential use as a chemotherapeutic drug. This study aimed to examine the effectiveness of polyethylene glycol?polycaprolactone (PEG?PCL) as a nanocarrier for DAS to increase its anticancer capabilities. The DAS?loaded PEG?PCL nanoparticles (termed as DAS@PEG?PCL NPs) were characterized using Fourier transform infrared (FTIR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and dynamic light scattering (DLS). Morphological staining and MTT tests were employed to investigate drug?loaded nanoparticles' apoptotic and anti?proliferative effects. The MTT assay demonstrated that incorporating DAS onto PEG?PCL NPs resulted in a dose?dependent increase in cytotoxicity in A549 (lung cancer) and HeLa (cervical cancer) cells. The A549 cancer cells were analyzed for their morphology using the acridine orange/ethidium bromide (AO/EB) and DAPI staining techniques. Overall, these findings demonstrate that the polymeric PEG?PCL nanoparticle systems hold great potential as a novel therapeutic strategy for cancer treatment.